Publication:
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

dc.contributor.authorsBeksac, Meral; Aydin, Yildiz; Goker, Hakan; Turgut, Mehmet; Besisik, Sevgi Kalayoglu; Cagirgan, Seckin; Tuglular, Tulin; Vural, Filiz; Yagci, Munci; Alacacioglu, Inci; Aytan, Pelin; Goksoy, Hasan Sami; Gulbas, Zafer; Gunes, Ahmet Kursad; Gurkan, Emel; Hacioglu, Sibel Kabukcu; Karti, Suleyman Sami; Kaynar, Leylagul; Ozdogu, Hakan; Paydas, Semra; Solmaz, Soner; Sonmez, Mehmet; Tekgunduz, Emre; Yildirim, Rahsan; Ilhan, Osman
dc.date.accessioned2022-03-02T05:41:10Z
dc.date.accessioned2026-01-10T18:35:05Z
dc.date.available2022-03-02T05:41:10Z
dc.date.issued2020-08
dc.identifier.doi10.1016/j.clml.2020.02.017
dc.identifier.issn21522650
dc.identifier.issue8
dc.identifier.pagese474-e484
dc.identifier.urihttps://hdl.handle.net/11424/218640
dc.identifier.volume20
dc.language.isoeng
dc.relation.urihttps://linkinghub.elsevier.com/retrieve/pii/S2152265020301142
dc.titleEarly Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format